Posted on

Investor became a billionaire after a psilocybin trip lead him to a new investment strategy

How Taking Magic Mushrooms Led To A Billion Dollar Fortune

After abstaining from drugs for decades, a German investor, Christian Angermayer, went on a life-changing mushroom trip that left him with profound insights and even made him understand Bitcoin. It was then that Angermayer decided to make radical changes to his investment strategy by focusing on things he’s passionate about.

During a second transformative mushroom trip, Angermayer had the idea to commercialize psychedelics, which led him to make an angel investment in Compass Pathways, a biotech company focused on psychedelic therapy. His stake in Compass Pathways is now worth $2 billion and he manages over $2.5 billion in assets.

PDF of article

Posted on

Soaking magic mushrooms in lemon juice can reduce nausea and heighten your trip

Magic Mushrooms: One Weird Trick Could Make Psilocybin Therapy Better

Soaking magic mushrooms in lemon juice can reduce nausea and heighten your trip. Simply grind the mushroom into a powder, add to a shot glass, submerge in lemon juice, stir, and drink immediately or within 20 minutes. Since lemon juice has a similar pH level as stomach acid, it helps breakdown beta-glucan, the compound in the mushrooms associated with nausea and upset stomach. This method can make your trip come on faster, shorten the trip, and increase its intensity because the acidic juice helps convert psilocybin into psilocin, the substance that makes you trip.

PDF of article

Posted on

Shark Tank’s Kevin O’Leary says investing in psychedelics has far more potential than cannabis

7 Investment Tips from Kevin O’Leary, Who Says There’s More Money In Psychedelics Than There Is In Cannabis

At a CNBC healthcare summit, Shark Tank venture capitalist Kevin O’Leary said that “the potential of psychedelics far exceeds the potential of cannabis”. O’Leary believes that the size and scale of the psychedelics market is appealing because of the lack of advancements in mental health treatment over the past several decades. O’Leary currently invests in MindMed and Compass Pathways, and advises investors to hold stakes in companies with multiple clinical trials.

PDF of article

Posted on

After suffering from depression for 22 years, actress Kristen Bell found relief and self-love from a single dose of psilocybin

Kristen Bell on Mushrooms: ‘I Really Wanted to Try Some Psilocybin’

After suffering from depression for 22 years, actress Kristen Bell found relief and self-love from a single dose of psilocybin. Kristen Bell became extremely interested in psychedelics and their power to change your mindset after reading How to Change Your Mind by Michael Pollan. Bell has suffered from waves of depression for 22 years and has tried everything from antidepressants and therapy to meditation. Bell took one dose of psilocybin, and stated that “the places you can go in your brain are much deeper and more healing than anything else”. Bell explains that the out of body experience she had while taking mushrooms gave her a sense of self love. “I had separated this body that had done so much good in my life, that has taken me through happiness and pain and workouts and laziness that I just, like, couldn’t stop touching my legs, going, ‘You’re so strong. You’re so elegant’ .”

PDF of article

Posted on

Get your Masters in Psychedelics

https://madison.com/wsj/news/local/health-med-fit/uw-madison-to-offer-pharmacy-masters-program-in-psychoactive-drugs/article_ac2ef5a8-b048-5a07-a5e7-474c4ce04502.html

“There’s going to be a big need to fill positions as this industry continues to grow.”

This fall, about 30 students will begin the master’s program in Psychoactive Pharmaceutical Investigation, a brand new two-year program at the University of Wisconsin Madison. The students will learn about drug development and delivery, regulations and ethical principles surrounding psychedelics, and the current challenges and breakthroughs in the field. In 2022, the university will also offer an accelerated version of the program.

Applications for the spring semester are open until Oct 31 –  don’t worry, it’s fully online so you won’t need to move to Wisconsin 😉

 

Posted on

Entheon’s psychedelics genetic test kit developed now available in Canada

Entheon Biomedical Corp. Launches HaluGen’s Psychedelics Genetic Test

Entheon Biomedical Corp. launched the first psychedelics genetic test kit through its subsidiary, HaluGen Life Sciences Inc. The kit includes a pre-screening mental health survey and cheek swab DNA test that will provide “genetic, personal and familial insights” to “better understand an individual’s sensitivity to classical psychedelics and ketamine”. The cheek swab tests for the HTR2A gene mutation,  a variant present in 20% of people that makes them more susceptible to strong hallucinations due to increased serotonin receptor density. Customers receive a personalized profile with sensitivity and risk reports to inform them before their next psychedelic experience.

PDF of article

Posted on

Losing weight with shrooms?

Psychedelic drug users tend to have better overall physical health than non-users, study finds

Psychedelic drug users might be healthier than non-users, according to a recent study.

A survey of over 170,000 people showed that those who have used psychedelic drugs (14% of respondents) reported better overall health and were significantly less likely to be overweight or obese compared to non-users. The University of Oxford researchers suggest that transcendent psychedelic experiences might result in “long-term changes in health behavior that contribute to better physical health.”

PDF of article

PDF of study

Posted on

How one dose of psilocybin healed decades of depression

‘They broke my mental shackles’: could magic mushrooms be the answer to depression?

A 56-year-old web developer named Michael was at one of the lowest points in his life after losing his mom to cancer and his friend to suicide. He had battled depression for over 30 years and was still in search of relief after trying several antidepressants and therapies.

He decided to participate in a psilocybin medical trial at Imperial College London, where he went on a five-hour psychedelic journey that turned his life around. The psilocybin-assisted therapy allowed him to relive childhood memories and confront his griefs.

“I became a different person,” Michael said. “I couldn’t wait to get dressed, get into the outside world, see people. I was supremely confident – more like I was when I was younger, before the depression started and got to its worst.”

Posted on

Taking shrooms is good for society

The relationships of classic psychedelic use with criminal behavior in the United States adult population

Research suggests that psychedelic drug use is linked to decreased criminal behaviour.

An analysis of 13 years worth of survey data revealed that psychedelic drug use was associated with decreased odds of past year theft, assault, arrest for property crime, and arrest for violent crimes by 27%, 12%, 22%, and 18%, respectively.

The use of other illegal drugs was associated with increased odds of criminal behaviour.

“These findings are consistent with a growing body of research suggesting classic psychedelics confer enduring psychological and prosocial benefits.”

Posted on

Two thirds of study participants say psilocybin trip was spiritually significant and increased life satisfaction

Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later

In a Johns Hopkins study, 36 volunteers who had never taken hallucinogens were given high doses of psilocybin. They were told to “focus explicitly on the phenomenology of the drug experience rather than perform tasks”. 14 months after the trip, 67% of participants rated it as one of the top five most spiritually significant experiences of their lives, and six people said it was the single most spiritually significant experience. 64% said the experience increased their well-being and life satisfaction.

PDF of study